Aurinia Pharmaceuticals AUPH Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's cash ratio?
- Aurinia Pharmaceuticals (AUPH) reported cash ratio of 0.5× in Q1 2026.
- How has Aurinia Pharmaceuticals's cash ratio changed year-over-year?
- Aurinia Pharmaceuticals's cash ratio decreased by 51.2% year-over-year, from 1× to 0.5×.
- What is the long-term trend for Aurinia Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's cash ratio has grown at a -36.8% compound annual growth rate (CAGR), from 8.5× to 0.9×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.